JAMA Ophthalmology : Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO
Interview with Ian Leslie. Mcallister, FRANZCO, author of Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial
Source: JAMA Specialty Journals Author Interviews - Category: General Medicine Source Type: podcasts
More News: Clinical Trials | General Medicine | Lucentis | Opthalmology | Ranibizumab Injection | Vitamin A